DEEPVESSEL PLAQUE
FDA-cleared stenosis and quantitative plaque analysis from CCTA. Request a demoDownload Product SHeet
See more than luminal narrowing.
CCTA reveals more than the presence of stenosis. DEEPVESSEL Plaque helps qualified clinicians assess the presence and extent of coronary atherosclerosis through quantitative plaque measurements, stenosis categorization, and visual clinical reports.
- Total plaque volume
- Non-calcified plaque volume
- Plaque burden
- Calcified plaque volume
- Low-density plaque volume
- CAD-RADS stenosis category
Quantitative findings. Visual context.
CCTA reveals more than the presence of stenosis. DEEPVESSEL Plaque helps qualified clinicians assess the presence and extent of coronary atherosclerosis through quantitative plaque measurements, stenosis categorization, and visual clinical reports.
CardiSight Overview Report
A visual overview of coronary anatomy, plaque location, and CAD-RADS stenosis category.
Plaque Analysis Report
Detailed vessel- and patient-level plaque volumes, burden, composition, and stenosis assessment.
AI-assisted analysis with trained analyst review.
Secure image transfer
Analysis and review
Clinical reports delivered
COMPOSE-CT Study
r = 0.976
Total plaque volume
r = 0.994
Calcified plaque volume
r = 0.945
Non-calcified plaque volume
0.810
CAD-RADS® weighted kappa
Comprehensive CCTA
Complementary insights. Separate clearances.
Ready to see what DEEPVESSEL Plaque can deliver?
For healthcare professionals in the United States